•
Jun 30, 2023

Solid Biosciences Q2 2023 Earnings Report

EPS
-$1.25
Previous year: -$3.3
-62.1%
Cash and Equivalents
$91.6M
Previous year: $163M
-43.8%
Free Cash Flow
-$28M
Previous year: -$17M
+64.6%
Total Assets
$205M
Previous year: $208M
-1.8%

Solid Biosciences

Solid Biosciences